Home  /  Resource Library  /  Combining Ixazomib With Subcutaneous Rituximab and Dexamethasone in Relapsed or Refractory Waldenstroms Macroglobulinemia: Final Analysis of the Phase I/II HOVON124/ECWM-R2 Study

Combining Ixazomib With Subcutaneous Rituximab and Dexamethasone in Relapsed or Refractory Waldenstroms Macroglobulinemia: Final Analysis of the Phase I/II HOVON124/ECWM-R2 Study

Results of a study investigating Ixazomib combined with Rituximab and dexamethasone for treatment of relapsed Waldenstrom’s macroglobulinemia.